PER® Miami Breast Cancer Conference | Conference

Emerging Therapies for HER2-Positive and Triple-Negative Breast Cancers

March 16th 2012

Recognition of breast cancer subtypes and research into their underlying biologies is driving the development of new therapies.

Dr. Gralow on Breast Cancer Adjuvant Bisphosphonates

March 16th 2012

Dr. Julie Gralow, from the Seattle Cancer Care Alliance, on Adjuvant Bisphosphonates for Breast Cancer

Immunotherapy Emerges as Promising Strategy in Breast Cancer

March 16th 2012

Next-generation immunotherapy in breast cancer treatment is an active field of scientific exploration with the potential to yield a vaccine.

Dr. Osman on the 29th Miami Breast Cancer Conference

March 15th 2012

Dr. Daniel Osman, the program chair for the Miami Breast Cancer Conference, Discusses the 29th Annual Meeting

Advances in Genomics Mask Complexities

March 15th 2012

Technological advances in genomics have prompted a "sea change" in breast cancer drug development and treatment.

Patients, Surgeons Face Hurdles in Making Breast Cancer Decisions

March 15th 2012

The choice of breast-conserving surgery over mastectomy is often based on fear of recurrence and death rather than clinical evidence.

29th Annual Miami Breast Cancer Conference Slideshow

March 15th 2012

Pictures from the Annual Miami Breast Cancer Conference, at the Fontainebleau Miami Beach hotel, in Florida.

Four Key Areas Are Focus of ASCO/SABCS Highlights

March 14th 2012

Debu Tripathy, MD, culled the highlights from abstracts presented in 2011 at the ASCO annual meeting in Chicago, Illinois, and at the CCTR-AARC SABCS in Texas.

29th Annual Miami Breast Cancer Conference Opens

March 14th 2012

The impact of molecular and genomic advancements on the treatment of patients with breast cancer will be among the prime topics of discussion.

Miami Breast Cancer Conference Founder Keeps Focus on Future

March 12th 2012

As the Miami Breast Cancer Conference enters its 29th year, Osman continues to organize the gathering and pack the 4-day meeting with faculty speakers.

Breast Reconstruction Trainee Assessment

March 18th 2011

In this podcast, Maisam Fazel, FRCS, MS, MB BChir, discusses his research into a checklist for breast cancer surgeons.

Dr. Osman on Designing the Program for the MBCC

March 16th 2011

Dr. Daniel Osman, director of the Miami Breast Cancer Conference, on Designing the Program for the MBCC

Dr. Fazel on Trends in Surgical Training

March 14th 2011

Maisam Fazel, FRCS, MS, MB BChir, of Imperial College Healthcare NHS Trust in the United Kingdom on Trends in Surgical Training

Need for Survivorship Plans Emphasized

March 14th 2011

As the number of breast cancer survivors grows, so does the emphasis on establishing individualized survivorship plans

Preoperative Therapy Offers Value to Patients

March 14th 2011

Preoperative neoadjuvant systemic therapy can be valuable for patients even if they do not achieve a pathologic complete response

Preoperative Therapy Offers Value to Patients

March 14th 2011

Preoperative neoadjuvant systemic therapy can be valuable for patients even if they do not achieve a pathologic complete response

Framework for Evaluating Trial Results Detailed

March 14th 2011

With thousands of clinical trials in play, many oncology specialists are reluctant to embrace findings from newly-released studies

Genomic Profiles as Routine Care Are a Hot Topic

March 14th 2011

Should genomic profiles be used routinely to determine which breast cancer patients receive adjuvant chemotherapy

Personalized Treatment With Adjuvant Chemotherapy Shows Marginal Progress

March 14th 2011

Personalized treatment in oncology is a popular concept these days, but the goal remains elusive

A Call for Change in Treating DCIS

March 11th 2011

It is time to rethink the way oncologists in the United States are treating ductal carcinoma in situ